← All trials
NCT00868283
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 1, 2006
- Primary completion
- Oct 1, 2010
- Completion date
- Feb 1, 2011
- First posted
- —
- Last posted
- —
- Enrollment
- 1071
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Ever Neuro Pharma GmbHLead sponsor
- Fudan UniversityOverall official - principal investigator
- EVER PharmaStudy director
- Excel PharmaStudies, Inc.Collaborator
- idv Datenanalyse und VersuchsplanungCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.